Retail traders lost ₹1.81 lakh crore in futures and options trading over three years to March 2024, with only 7.2% making a profit, according to Sebi. The number of retail traders nearly doubled, contributing significantly to total turnover. Sebi plans to tighten rules to curb risky speculation among retail investors.
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab
AstraZeneca Pharma Share Price: The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).